Abstract 3158: Pharmacokinetic and biodistribution evaluation of nebivolol and dasatinib in the 4T1 triple-negative breast cancer model: Implications for drug-drug interaction
Airong Li(University of Houston), Diana S.-L. Chow(University of Houston), Fatima Dagher(University of Houston), Mikayla Skillman(University of Houston), Benny Abraham Kaipparettu(Children's Cancer Center), Emanuel Baltrip(University of Houston), Junhyoung Park(Baylor College of Medicine), Amir Mohammad Gholizadeh(University of Houston), Meghana V. Trivedi(University of Houston)
Cited by 1
Related Papers
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma
|Cell Reports|2016|382
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
|Cell Reports|2016|320
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2013|273
Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize
|Cancer Research|2018|221